Advanced search
Publication Cover
International Journal of Circumpolar Health Volume 73, 2014 - Issue 1
Submit an article Journal homepage
488
Views
5
CrossRef citations to date
0
Altmetric
Original Research Articles

Impact of pneumococcal vaccines use on invasive pneumococcal disease in Nunavik (Quebec) from 1997 to 2010

Jean-Baptiste Le MeurQuebec Heart and Lung Institute Research Centre, Quebec City, Canada;Department of Social and Preventive MedicineLaval University, Quebec City, Canada
,
Brigitte LefebvreQuebec Public Health Laboratory (Laboratoire de santé publique du Québec), Quebec National Institute of Public Health (Institut national de santé publique du Québec), Ste-Anne-de-Bellevue, Canada
,
Jean-François ProulxPublic Health DirectorateNunavik Regional Board of Health and Social Services, Kuujjuaq, Canada
,
Serge DéryPublic Health DirectorateNunavik Regional Board of Health and Social Services, Kuujjuaq, Canada
,
Jacques PépinDepartment of Microbiology and Infectious DiseasesUniversity of Sherbrooke, Sherbrooke, Canada;Etienne-Lebel Research Centre, Sherbrooke University Hospital, Sherbrooke, Canada
&
Philippe De WalsQuebec Heart and Lung Institute Research Centre, Quebec City, Canada;Department of Social and Preventive MedicineLaval University, Quebec City, Canada;Etienne-Lebel Research Centre, Sherbrooke University Hospital, Sherbrooke, CanadaCorrespondence[email protected]
Article: 22691 | Received 16 Sep 2013, Accepted 03 Nov 2013, Published online: 17 Jan 2014

References

  • MacMillan HI, MacMillan AB, Offord DR, Dingle JL. Aboriginal health. CMAJ. 1996; 155: 1569–76. [PubMed Abstract] [PubMed CentralFull Text].
  • Degani N, Navarro C, Deeks SL, Lovgren M. Invasive bacterial diseases in northern Canada. Emerg Infect Dis. 2008; 14: 34–40.
  • Marcy JF, Roberts A, Lior L, Tam TWS, VanCaeseele P. Outbreak of community-acquired pneumonia in Nunavut, October and November 2000. Can Commun Dis Rep. 2002; 28: 131–8.
  • Proulx JF, Déry S, Jetté L, Ismaël J, Libman M, De Wals P. Pneumonia epidemic caused by a virulent strain of Streptococcus pneumoniae serotype 1 in Nunavik, Quebec. Can Commun Dis Rep. 2002; 28: 129–31.
  • Ndiaye AA, De Wals P, Proulx JF, Ouakki M, Jetté L, Déry S. Impact of a mass immunization campaign to control an outbreak of severe respiratory infections in Nunavik, northern Canada. Int J Circumpolar Health. 2006; 65: 297–304.
  • Douville-Fradet M, Amini R, Boulianne N, Khuc NH, De Wals P, Fortin E, etal. Impact du programme d'immunisation par le vaccin pneumococcique conjugué heptavalent (VPC-7) au Québec [Impact of the Immunization Program with a 7-Valent Pneumococcal Conjugate Vaccine in the Province of Québec, Canada]. 2011; Québec: Institut national de santé publique du Québec. 99.
  • Lefebvre B, Bourgault AM. Programme de surveillance du pneumocoque: Rapport 2010. 2012; Québec: Institut national de santé publique du Québec. 42 p+annexes.
  • Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, etal. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006; 368: 1495–502.
  • Wenger J, Zulz T, Bruden D, Singleton R, Bruce MG, Bulkow L, etal. Invasive pneumococcal disease in Alaskan children. Pediatr Infect Dis J. 2010; 29: 251–6.
  • Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults (Review). Cochrane Database Syst Rev. 2013. Article no.: CD000422.
  • Singleton RJ, Butler JC, Bulkow LR, Hurlburt D, O'Brien KL, Doan W, etal. Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults. Vaccine. 2007; 25: 2288–95.
  • Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, etal. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991; 325: 1453–60.
  • Dagan R, Lipsitch M, Tuomanen EI, Mitchell TJ, Morrisson DA, Spratt BG. Changing the ecology of pneumococci with antibiotics and vaccines. The pneumococcus. 2004; Washington, DC: ASM Press. 283–313.
  • Benin AL, O'Brien KL, Watt JP, Reid R, Zell R, Katz S, etal. Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults. J Infect Dis. 2003; 188: 81–9.
  • Said MA, O'Brien KL, Pekka Nuorti J, Singleton R, Whitney CG, Hennessy TW. The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations. Vaccine. 2011; 29: 5355–62.
  • Bruce MG, Deeks SL, Zulz T, Bruden D, Navarro C, Lovgren M, etal. International circumpolar surveillance system for invasive pneumococcal disease, 1999–2005. Emerg Infect Dis. 2008; 214: 25–33.
  • Hausdorff WP, Brueggemann AB, Hackell , Scott JAG, Siber GR, Klugman KP, Mäkelä PH. Pneumococcal serotype epidemiology. Pneumococcal vaccines: the impact of conjugate vaccine. 2008; Washington, DC: ASM Press. 139–53.
  • De Wals P, Lefebvre B, Markowski F, Deceuninck G, Defay F, Douville-Fradet M, etal. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine. Accepted for publication.
Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.